Project Details
| Status | Active |
|---|---|
| Effective start/end date | 13/10/25 → 12/10/30 |
Clinical Trial Phase
- Phase II
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia
- Mansfield, Darren (Primary Chief Investigator (PCI))
Project: Research